News & Updates

In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.

Several factors, including male sex and reported cough, influence the decisions by clinicians to initiate tuberculosis (TB) treatment among individuals who receive a negative result on an initial bacteriological test for TB, reports a study.

Patients who had been infected with COVID-19 continue to experience symptoms at medium-term follow-up, showing greater high-sensitivity C-reactive protein (hsCRP) than controls, results of a study have shown.

Individuals with inflammatory bowel disease (IBD) appear to be at greater risk of developing chronic obstructive pulmonary disease (COPD) and asthma, suggests a study.

A remotely delivered structured weight management programme appears effective and safe in reducing symptoms that matter most among individuals with long COVID (LC) and overweight, findings from the wait-list-controlled open-label ReDIRECT trial suggest.